Gorgas Torner M Q, Odena Estradé E, Pastor Solernou F
Servicio de Farmacia, Hospital Comarcal Sant Bernabé, Berga, Barcelona.
Farm Hosp. 2003 Sep-Oct;27(5):280-9.
Drug therapy-induced high morbidity results in pharmacists participating in the prevention and solution of drug-related problems (DRPs).
To assess DRP prevalence amongst inpatients, and the clinical results derived from pharmaceutical intervention.
DRPs detected during 6 months at Hospital Comarcal de Sant Bernabé were recorded and classified, and their severity established. Pharmaceutical intervention was evaluated by using two codes: impact and clinical significance. Interventions were reassessed by another pharmacist and a physician, and the degree of agreement was calculated.
The prevalence of DRPs amongst inpatients was 10.8%. A total of 425 DRPs was detected, with a mean of 1.51 DRPs/patient. The highest percentage involved inappropriate drugs (26%), overdosing (22%), and inadequate dosing (22%). Eighty-four percent of DRPs were a severity level 2. Drugs mainly involved were antibiotics (21.6%), anti-ulcer agents (21.8%), and analgesic-anti-inflammatory compounds (8.1%). In all, 58% of interventions impacted on treatment effectiveness, and 42% on toxicity. Intervention acceptance was 91%. Seventy percent of interventions were appropriate and highly significant. The percentage of agreements in reassessments exceeded 88%.
Pharmaceutical care allows DRPs to be prevented and solved. Methodology validation makes it safer in daily practice.
药物治疗导致的高发病率促使药剂师参与药物相关问题(DRP)的预防和解决。
评估住院患者中DRP的患病率,以及药物干预产生的临床结果。
记录并分类在圣伯纳贝地区医院6个月期间检测到的DRP,并确定其严重程度。使用两个代码评估药物干预:影响和临床意义。由另一名药剂师和一名医生对干预措施进行重新评估,并计算一致程度。
住院患者中DRP的患病率为10.8%。共检测到425个DRP,平均每位患者1.51个DRP。涉及比例最高的是用药不当(26%)、用药过量(22%)和剂量不足(22%)。84%的DRP严重程度为2级。主要涉及的药物有抗生素(21.6%)、抗溃疡药(21.8%)和止痛抗炎化合物(8.1%)。总体而言,58%的干预措施影响治疗效果,42%影响毒性。干预接受率为91%。70%的干预措施是适当且具有高度意义的。重新评估中的一致率超过88%。
药学服务能够预防和解决DRP。方法学验证使其在日常实践中更安全。